GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mediclinic International PLC (OTCPK:ANHGY) » Definitions » Piotroski F-Score

Mediclinic International (Mediclinic International) Piotroski F-Score : 0 (As of May. 11, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Mediclinic International Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Mediclinic International has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Mediclinic International's Piotroski F-Score or its related term are showing as below:


Mediclinic International Piotroski F-Score Historical Data

The historical data trend for Mediclinic International's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mediclinic International Piotroski F-Score Chart

Mediclinic International Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 5.00 4.00 6.00 6.00

Mediclinic International Semi-Annual Data
Mar13 Sep13 Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 6.00 - 6.00 -

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar22) TTM:Last Year (Mar21) TTM:
Net Income was $199 Mil.
Cash Flow from Operations was $730 Mil.
Revenue was $4,260 Mil.
Gross Profit was $665 Mil.
Average Total Assets from the begining of this year (Mar21)
to the end of this year (Mar22) was (9253.814 + 9495.389) / 2 = $9374.6015 Mil.
Total Assets at the begining of this year (Mar21) was $9,254 Mil.
Long-Term Debt & Capital Lease Obligation was $3,186 Mil.
Total Current Assets was $1,942 Mil.
Total Current Liabilities was $1,084 Mil.
Net Income was $94 Mil.

Revenue was $4,154 Mil.
Gross Profit was $591 Mil.
Average Total Assets from the begining of last year (Mar20)
to the end of last year (Mar21) was (8606.436 + 9253.814) / 2 = $8930.125 Mil.
Total Assets at the begining of last year (Mar20) was $8,606 Mil.
Long-Term Debt & Capital Lease Obligation was $3,076 Mil.
Total Current Assets was $1,709 Mil.
Total Current Liabilities was $949 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Mediclinic International's current Net Income (TTM) was 199. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Mediclinic International's current Cash Flow from Operations (TTM) was 730. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar21)
=198.946/9253.814
=0.02149881

ROA (Last Year)=Net Income/Total Assets (Mar20)
=94.313/8606.436
=0.01095843

Mediclinic International's return on assets of this year was 0.02149881. Mediclinic International's return on assets of last year was 0.01095843. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Mediclinic International's current Net Income (TTM) was 199. Mediclinic International's current Cash Flow from Operations (TTM) was 730. ==> 730 > 199 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar21 to Mar22
=3185.771/9374.6015
=0.33983002

Gearing (Last Year: Mar21)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar20 to Mar21
=3076.283/8930.125
=0.34448376

Mediclinic International's gearing of this year was 0.33983002. Mediclinic International's gearing of last year was 0.34448376. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar22)=Total Current Assets/Total Current Liabilities
=1942.029/1084.321
=1.7910093

Current Ratio (Last Year: Mar21)=Total Current Assets/Total Current Liabilities
=1708.738/948.682
=1.80117047

Mediclinic International's current ratio of this year was 1.7910093. Mediclinic International's current ratio of last year was 1.80117047. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Mediclinic International's number of shares in issue this year was 737.288. Mediclinic International's number of shares in issue last year was 737.244. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=665.349/4259.552
=0.15620164

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=590.846/4153.953
=0.14223705

Mediclinic International's gross margin of this year was 0.15620164. Mediclinic International's gross margin of last year was 0.14223705. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar21)
=4259.552/9253.814
=0.46030231

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar20)
=4153.953/8606.436
=0.48265658

Mediclinic International's asset turnover of this year was 0.46030231. Mediclinic International's asset turnover of last year was 0.48265658. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+0+0+1+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Mediclinic International has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Mediclinic International  (OTCPK:ANHGY) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Mediclinic International Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Mediclinic International's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Mediclinic International (Mediclinic International) Business Description

Traded in Other Exchanges
N/A
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
Mediclinic International PLC is a UK based international private healthcare group. It is engaged in offering acute care, specialist-orientated and multi-disciplinary healthcare services, by operating many hospitals and clinics. The geographic operating segments of the company are Mediclinic Southern Africa, Mediclinic Switzerland, and Mediclinic Middle East. It derives the majority of the revenue from the Switzerland segment. The other non-operating segments of the company are the United Kingdom and Corporate. The group's operations are carried out under the Mediclinic and Hirslanden brand.

Mediclinic International (Mediclinic International) Headlines